146 related articles for article (PubMed ID: 24590757)
1. Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.
Maschan M; Bobrynina V; Khachatryan L; Kalinina I; Solopova G; Avdonin P; Nasedkina T; Novichkova G; Maschan A
Pediatr Blood Cancer; 2014 Oct; 61(10):1871-3. PubMed ID: 24590757
[TBL] [Abstract][Full Text] [Related]
2. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
Tüfekçi Ö; Ören H; Demir Yenigürbüz F; Gözmen S; Karapınar TH; İrken G
Turk J Haematol; 2015 Jun; 32(2):175-9. PubMed ID: 26316488
[TBL] [Abstract][Full Text] [Related]
3. Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
Stieglitz E; Ward AF; Gerbing RB; Alonzo TA; Arceci RJ; Liu YL; Emanuel PD; Widemann BC; Cheng JW; Jayaprakash N; Balis FM; Castleberry RP; Bunin NJ; Loh ML; Cooper TM
Pediatr Blood Cancer; 2015 Apr; 62(4):629-36. PubMed ID: 25704135
[TBL] [Abstract][Full Text] [Related]
4. Juvenile myelomonocytic leukemia with PTPN11 mutation in a 23-month-old girl.
Jakovljević G; Kardum-Skelin I; Rogosić S; Nakić M
Coll Antropol; 2010 Mar; 34(1):251-4. PubMed ID: 20432758
[TBL] [Abstract][Full Text] [Related]
5. Development of T-cell acute lymphoblastic leukemia in a patient in very long lasting complete remission of juvenile myelomonocytic leukemia.
Maschan AA; Khachatrian LA; Solopova GG; Ossipova EY; Baidun LV; Dmitrieva SV; Maschan MA; Resnik IB
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e32-4. PubMed ID: 21102353
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
[No Abstract] [Full Text] [Related]
7. The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia.
De Filippi P; Zecca M; Novara F; Lisini D; Maserati E; Pasquali F; Rosti V; Carlo-Stella C; Zavras N; Cagioni C; Zuffardi O; Pagliara D; Danesino C; Locatelli F
Pediatr Blood Cancer; 2012 Sep; 59(3):580-2. PubMed ID: 22183880
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytosis associated with leukemia: a striking association with juvenile myelomonocytic leukemia.
Unal S; Cetin M; Kutlay NY; Elmas SA; Gumruk F; Tukun A; Tuncer M; Gurgey A
Ann Hematol; 2010 Apr; 89(4):359-64. PubMed ID: 19798502
[TBL] [Abstract][Full Text] [Related]
9. Juvenile myelomonocytic leukaemia and Noonan syndrome.
Strullu M; Caye A; Lachenaud J; Cassinat B; Gazal S; Fenneteau O; Pouvreau N; Pereira S; Baumann C; Contet A; Sirvent N; Méchinaud F; Guellec I; Adjaoud D; Paillard C; Alberti C; Zenker M; Chomienne C; Bertrand Y; Baruchel A; Verloes A; Cavé H
J Med Genet; 2014 Oct; 51(10):689-97. PubMed ID: 25097206
[TBL] [Abstract][Full Text] [Related]
10. [Gene mutations and clinical characteristics in children with juvenile myelomonocytic leukemia].
Yang WY; Chen XJ; Wang SC; Guo Y; Liu TF; Chang LX; Liu F; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):1-5. PubMed ID: 25616283
[TBL] [Abstract][Full Text] [Related]
11. [Molecular biology of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2010 Jul; 51(7):526-31. PubMed ID: 20693772
[No Abstract] [Full Text] [Related]
12. Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML.
Takagi M; Piao J; Lin L; Kawaguchi H; Imai C; Ogawa A; Watanabe A; Akiyama K; Kobayashi C; Mori M; Ko K; Sugimoto M; Mizutani S
Leukemia; 2013 Sep; 27(9):1926-8. PubMed ID: 23503607
[No Abstract] [Full Text] [Related]
13. Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.
Muraoka M; Okuma C; Kanamitsu K; Ishida H; Kanazawa Y; Washio K; Seki M; Kato M; Takita J; Sato Y; Ogawa S; Tsukahara H; Oda M; Shimada A
J Hum Genet; 2016 Jun; 61(6):523-6. PubMed ID: 26911351
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.
Matsuda K; Sakashita K; Taira C; Tanaka-Yanagisawa M; Yanagisawa R; Shiohara M; Kanegane H; Hasegawa D; Kawasaki K; Endo M; Yajima S; Sasaki S; Kato K; Koike K; Kikuchi A; Ogawa A; Watanabe A; Sotomatsu M; Nonoyama S; Koike K
Br J Haematol; 2010 Feb; 148(4):593-9. PubMed ID: 19874312
[TBL] [Abstract][Full Text] [Related]
15. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Caye A; Strullu M; Guidez F; Cassinat B; Gazal S; Fenneteau O; Lainey E; Nouri K; Nakhaei-Rad S; Dvorsky R; Lachenaud J; Pereira S; Vivent J; Verger E; Vidaud D; Galambrun C; Picard C; Petit A; Contet A; Poirée M; Sirvent N; Méchinaud F; Adjaoud D; Paillard C; Nelken B; Reguerre Y; Bertrand Y; Häussinger D; Dalle JH; Ahmadian MR; Baruchel A; Chomienne C; Cavé H
Nat Genet; 2015 Nov; 47(11):1334-40. PubMed ID: 26457648
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine.
Wajid M A; Gupta AK; Das G; Sahoo D; Meena JP; Seth R
Pediatr Hematol Oncol; 2020 Oct; 37(7):573-581. PubMed ID: 32459546
[TBL] [Abstract][Full Text] [Related]
17. Successful remission of thrombotic thrombocytopenic purpura with rituximab in a patient with undifferentiated connective tissue disorder.
Gupta D; Roppelt H; Bowers B; Kunz D; Natarajan M; Gruber B
J Clin Rheumatol; 2008 Apr; 14(2):94-6. PubMed ID: 18391679
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Landscape of NRAS- mutated Juvenile Myelomonocytic Leukemia-like Myeloproliferation Includes Children With Costello Syndrome.
Pabari R; Chun K; Naqvi A
J Pediatr Hematol Oncol; 2023 Apr; 45(3):e401-e405. PubMed ID: 35665722
[TBL] [Abstract][Full Text] [Related]
19. Juvenile myelomonocytic leukemia presenting with coexistent cytomegalovirus infection--a case report.
Prabhu SB; Gupta R; Seth R
J Pediatr Hematol Oncol; 2010 May; 32(4):e153-4. PubMed ID: 20445410
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].
Koike K; Matsuda K
Rinsho Ketsueki; 2013 Jun; 54(6):538-44. PubMed ID: 23823092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
